Susan Gauthier is a Neurology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1305 York Ave
Suite Y217
New York, NY 100215663
Telephone
646-962-9800Registry record last updated 28 Dec 2012.
Clinical trials
- Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS
Sponsor: Weill Medical College of Cornell University
- Measuring Active Microglia in Progressive Multiple Sclerosis
Sponsor: Weill Medical College of Cornell University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Genentech, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
50%Gabapentinoids14.1%Pregabalin53%Gabapentin48%Part D<11 patientsSympathomimetic-like Agent8.1%Modafinil100%Part D<11 patients+ 5 more classes in this area
Cancer & immunology
29.9%Other immunostimulants12.7%Copaxone100%Part D<11 patientsPyrimidine Synthesis Inhibitor7.7%Teriflunomide100%Part D<11 patients+ 2 more classes in this area
Musculoskeletal
11.3%gamma-Aminobutyric Acid-ergic Agonist11.3%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Multi-Scale, Multi-Modal Imaging Assessment of Trajectories of Cognitive Impairment in Multiple Sclerosis
Weill Medical Coll of Cornell Univ
FY2026$663,449R01NS134646 - Quantification of the Innate Immune Activity within Chronic Lesions as a Novel Treatment Biomarker in Multiple Sclerosis
Weill Medical Coll of Cornell Univ
FY2026$626,221R01NS136864 - Multi-Scale, Multi-Modal Imaging Assessment of Trajectories of Cognitive Impairment in Multiple Sclerosis
Weill Medical Coll of Cornell Univ
FY2025$667,279R01NS134646
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”